JPRN-UMIN000011567已完成未知
The efficancy of a new long-acting insulin degludec in patient with diabetes - The efficancy of a new long-acting insulin degludec in patient with diabetes
Osaka Saiseikai Noe Hospital0 个研究点目标入组 100 人开始时间: 2013年8月31日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Contraindicated patient in the attached document of insulin degludec Contraindicated patient in the attached document of diabetes drugs Hypoglycemic risk Serious heart trouble Severe hepatic dysfunction Severe renal dysfunction Internal secretion disease Needs the steroid dosage Patients judged by the investigator to be ineligible for some other reason
研究者
相似试验
已完成
4 期
The efficacy of insulin degludec/insulin aspart switching from insulin glargine or degludec about glycemic metabolism in type 2 diabetes patientsType 2 diabetesJPRN-UMIN000025199Hokkaido University Hospital60
招募中
不适用
Investigation of the usefulness of insulin degludec in patients with type 1 diabetestype 1 diabetesJPRN-UMIN000010893Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine, Hyogo College of Medicine20
招募中
不适用
Study of the efficacy and safety of insulin degludec who treating with basal insulin glargine or insulin detemir in type 1 diabetes with the Basal-Bolus TherapyType 1 diabetesJPRN-UMIN000012358Toho University School of Medicine, Division of diabetes, metabolism and endocrinology20
招募中
不适用
Study of the efficacy and safety of insulin degludec who treating with basal insulin glargine or insulin detemir in type 2 diabetes with the Basal-Bolus TherapyJPRN-UMIN000015792Toho University School of Medicine, Division of diabetes, metabolism and endocrinology40
进行中（未招募）
不适用
The efficacy of insulin degludec/liraglutide as add-on therapy in controlling glycaemia in adults with type 2 diabetes inadequately controlled on sulphonylurea with or without metformin therapyDiabetes mellitus, Type 2MedDRA version: 15.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2012-000140-97-DEovo Nordisk A/S429